期刊文献+

阿尔茨海默病的促认知药物治疗 被引量:3

Cognitive enhancer in the treatment of Alzheimer's disease
下载PDF
导出
摘要 促认知药物用以改善患者认知功能或延缓认知功能的衰退。本文参考Cochrane Library资料库(2010年第1期)中"Cochrane Dementia and Cognitive Improvement Group"的系统综述,对国内外有关阿尔茨海默病(AD)的促认知药物治疗进行归纳概括,以期为AD的药物治疗提供参考。 Cognitive enhancer can improve cognitive function and delay the decline of cognitive function in Alzheimer's disease (AD)patients. Followed a review, "Cochrane Dementia and Cognitive Improvement Group", this review describes the domestic and overseas researches on cognitive enhancer, in order to provide reference for the treatment of AD in clinic.
出处 《世界临床药物》 CAS 2010年第7期399-403,共5页 World Clinical Drug
基金 科技部支撑计划(2009BAI77B03)
关键词 阿尔茨海默病 促认知药物 治疗 Alzheimer's disease cognitive enhancer therapy
  • 相关文献

参考文献23

  • 1Cummings JL. Alzheimer's disease [J]. N Engl J Med, 2004, 351(1): 56-67.
  • 2Doody, RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2001, 56 (9): 1154-1166.
  • 3The Cochrane Library. Cochrane Dementia and Cognitive hnprovement Group[EB/OL]. (2010-01-14) [2010-03-241. http://www.mrw.interscience.wiley.com/cochrane/cochrane_ crglist_fs.html.
  • 4Palacios JM. Alzheimer's disease: new pharmacological perspectives [J]. Methods Find Exp Clin Pharmacol, 1996, 18 (Suppl B) : S67-S68.
  • 5Jann, MW. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease [J]. Pharmacotherapy, 2000, 20 (1) : 1-12.
  • 6Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease[J]. Prescrire Int, 2001, 10(56): 180-181.
  • 7Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial[J]. JAm Med Assoc, 2004, 291 (3) : 317-324.
  • 8Cirrito JR, Holtzman DM. Amyloid beta and Alzheimer disease therapeutics: the devil may be in the details [J]. J Clin Invest, 2003, 112 (3) : 321-323.
  • 9Sano M. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease [J]. N Engl J Med, 1997, 336(17): 7.
  • 10Klatte ET, Scharre DW, Nagaraja HN, et al. Combination therapy of donepezil and vitamin E in Alzheimer disease [J]. Alzheimer Dis Assoc Disord, 2003, 17 (2) : 113-116.

二级参考文献32

  • 1梁平,潘阳杏,赵雪梅,杜洪震,张冀民.早老素1基因在转染CHO细胞中的表达及其与γ-分泌酶的关系[J].中华病理学杂志,2005,34(5):297-301. 被引量:10
  • 2陈新平,陈彪.阿尔茨海默病病因学及发病机制研究进展[J].中国现代神经疾病杂志,2005,5(3):152-155. 被引量:27
  • 3金伟秋.Neotrofin 在阿尔茨海默氏病试验中失分[J].国外药讯,2002,(8):13-15.
  • 4Kofler B, Erhart C, Erhart P, et al. A multidimensional approach in tesing nootripic drug effects(Cerebrolysin) [J]. Arck Gerontol Geriatr 1990,10:129 - 140.
  • 5Akai F, Hiruma S, Sato T et al. Neurotrophic factor-like effect of 1070 on septal cholinergic neurones after transitions of fimobrio-fornix in the rat brain [J]. Histol Histopathol , 1992, 7:213 - 221.
  • 6Albrecht E, Hingel S . The effects of cerebrolysin on the vitality and sprouting of neurons from cerebral hemispheres and from the brain stem of chicken embryos in vitro [J]. Neurobiol Aging, 1992,13 [Suppl 1 ]: S127.
  • 7Baskys A,Wojtowicz JN Actions of organ derived preperations on synaptic transmission in the hippocampus [J]. Neorobiol Aging , 1992, 13[Suppl 1]: 128.
  • 8Shimazu S, lwamoto N, Itoh T, et al . Neurotrophic activity of cerebrolysin , Second Interntional Springfield Symposium on Advantage in Alzheimer Therapy [M].USAS: pringfiuld,1991. 51.
  • 9Xiong H , Wojtowicz J, Baskys A. Brain tissue hydrolysate acts on presynapitc adenosine receptors in the rat hippocampus [J]. Can J Physiol Pharmacol 1995.73:1 194 -1197.
  • 10Piswanger A, Paier B, Windisch M. Modulation of protein synthesis in a cell-free system from rat brain by cerebrolysin during development and aging [J] Amino Acids, 1990,4: 651 - 657.

共引文献16

同被引文献57

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部